Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002099.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 2.19 1.49 1.45
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 9.68 -2.92 2.66
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -20.30 3.40 4.27
Cash 18.81 1.27 1.07
Capex -2595.64 -0.01 < 0.005
Free Cash Flow -87.66 < 0.005 -0.02
Revenue -13.96 0.32 0.38
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 678.78 0.31 -0.04
Operating Margin -93.53 0.05 -0.85
ROA -91.60 < 0.005 -0.05
ROE -91.36 < 0.005 -0.07
ROIC -92.08 < 0.005 -0.06
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002099.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002099.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002099.SZ is permitted for members.